A Tradition of Innovation
Established in 1945, Grupo PiSA Farmacéutica is one of the largest manufacturers of medical products in the world. Professor Don Miguel Alvarez Ochoa named the original company Productos Infantiles, S.A., or PiSA for short. The Mexican pharmaceutical giant has led the industry in quality, innovation, and patient safety for seven decades.
Grupo PiSA Farmacéutica hosts the largest distribution network in Mexico with 14 manufacturing sites, 5 warehouses, and 11 platform crossings. They also serve more than 20 international pharmaceutical companies as a contract manufacturer, and has been awarded the Certification of Quality ISO as well as the ESR Certification of Clean Industry. Today, the company boasts a portfolio of 1500 products and dozens of corporate subsidiaries and descendants around the globe.
Breaking Into the U.S. Market
In 2014, PiSA BioPharm was founded as a CMO to produce products for the U.S. Market. They are uniquely positioned to design, develop, manufacture, and market products that are driven by industry needs.
Today, PiSA BioPharm provides the majority of the renal and respiratory fluid products to the U.S. market through its partners. After establishing themselves as a trusted contract manufacturing enterprise, the company’s leadership turned its focus to the possibility of commercializing products under its own label.
Founded in 2020, Hometa is an independently operated entity focused on the procurement, development, and commercialization of medical devices for the U.S. Market.
Hometa boasts two novel infusion products that reduce cost and complexity while improving clinical outcomes; the DripAssist® Infusion Rate Monitor, designed to monitor gravity infusions, is the only one commercially available in the United Sates. The DripAssist® counts drops with 99% accuracy for constant, reliable monitoring of any medication or fluid on gravity infusion. Hometa’s IV bags are made with durable Ethylene Vinyl Acetate (EVA) with an interior linear embossed lining. They are some of the only IV bags on the market to be 100% leak tested and responsibly sterilized by EtO. Hometa plans to offer a full bag-to-vein portfolio by the end of 2023.